BioCentury | Jan 26, 2015
Analyst Picks & Changes

Analyst picks & changes

...$20.9M in 4Q13. The 4Q14 revenue figure includes $8.2M from the February 2014 acquisition of DVS Sciences Inc....
BioCentury | Apr 28, 2014
Analyst Picks & Changes

Analyst picks & changes

...which should be positives for the microfluidics company. He also said the February acquisition of DVS Sciences Inc....
BioCentury | Apr 21, 2014
Analyst Picks & Changes

Analyst picks & changes

...single cell gene expression analysis tools remains strong." He also said Fluidigm's February acquisition of DVS Sciences Inc....
BioCentury | Feb 17, 2014
Company News

Fluidigm, DVS Sciences deal

...Microfluidics company Fluidigm completed its acquisition of DVS Sciences, which develops and markets single-cell protein analysis systems...
...cash and stock deal (see BioCentury, Feb. 3). Fluidigm Corp. (NASDAQ:FLDM), South San Francisco, Calif. DVS Sciences Inc....
BioCentury | Feb 10, 2014
Analyst Picks & Changes

Analyst picks & changes

...increased concentration in sample preparation vs. the higher revenue-generating analytical tools base. Fluidigm is acquiring DVS Sciences Inc....
BioCentury | Feb 3, 2014
Company News

Fluidigm, DVS Sciences deal

...Microfluidics company Fluidigm is acquiring DVS Sciences for about $207.5 million in a cash and stock deal...
...& Watkins LLP is the company's legal advisor. Fluidigm Corp. (NASDAQ:FLDM), South San Francisco, Calif. DVS Sciences Inc....
BioCentury | Feb 3, 2014
Finance

Quick payday on single cell sale

...A quick turnaround from first financing to takeout netted investors in DVS Sciences Inc. an impressive return in...
BioCentury | Jan 30, 2014
Company News

Fluidigm to acquire DVS Sciences

...Microfluidics company Fluidigm Corp. (NASDAQ:FLDM) is acquiring DVS Sciences Inc. (Sunnyvale, Calif.) for about $207.5 million in a...
BioCentury | Sep 13, 2012
Distillery Techniques

Technology: Drug platforms

...and metabolic pathways in cancer cells. The method used in the paper is marketed by DVS Sciences Inc....
...5(36); doi:10.1038/scibx.2012.968 Published online Sept. 13, 2012 Flow cytometry method covered by patents owned by DVS Sciences...
BioCentury | Aug 27, 2012
Tools & Techniques

Network profiling

...to find partners to develop and commercialize treatments for cancer and autoimmune indications using SCNP. DVS Sciences Inc....
...is on DVS's scientific advisory board. Companies and Institutions Mentioned Celgene Corp. (NASDAQ:CELG), Summit, N.J. DVS Sciences Inc....
Items per page:
1 - 10 of 15
BioCentury | Jan 26, 2015
Analyst Picks & Changes

Analyst picks & changes

...$20.9M in 4Q13. The 4Q14 revenue figure includes $8.2M from the February 2014 acquisition of DVS Sciences Inc....
BioCentury | Apr 28, 2014
Analyst Picks & Changes

Analyst picks & changes

...which should be positives for the microfluidics company. He also said the February acquisition of DVS Sciences Inc....
BioCentury | Apr 21, 2014
Analyst Picks & Changes

Analyst picks & changes

...single cell gene expression analysis tools remains strong." He also said Fluidigm's February acquisition of DVS Sciences Inc....
BioCentury | Feb 17, 2014
Company News

Fluidigm, DVS Sciences deal

...Microfluidics company Fluidigm completed its acquisition of DVS Sciences, which develops and markets single-cell protein analysis systems...
...cash and stock deal (see BioCentury, Feb. 3). Fluidigm Corp. (NASDAQ:FLDM), South San Francisco, Calif. DVS Sciences Inc....
BioCentury | Feb 10, 2014
Analyst Picks & Changes

Analyst picks & changes

...increased concentration in sample preparation vs. the higher revenue-generating analytical tools base. Fluidigm is acquiring DVS Sciences Inc....
BioCentury | Feb 3, 2014
Company News

Fluidigm, DVS Sciences deal

...Microfluidics company Fluidigm is acquiring DVS Sciences for about $207.5 million in a cash and stock deal...
...& Watkins LLP is the company's legal advisor. Fluidigm Corp. (NASDAQ:FLDM), South San Francisco, Calif. DVS Sciences Inc....
BioCentury | Feb 3, 2014
Finance

Quick payday on single cell sale

...A quick turnaround from first financing to takeout netted investors in DVS Sciences Inc. an impressive return in...
BioCentury | Jan 30, 2014
Company News

Fluidigm to acquire DVS Sciences

...Microfluidics company Fluidigm Corp. (NASDAQ:FLDM) is acquiring DVS Sciences Inc. (Sunnyvale, Calif.) for about $207.5 million in a...
BioCentury | Sep 13, 2012
Distillery Techniques

Technology: Drug platforms

...and metabolic pathways in cancer cells. The method used in the paper is marketed by DVS Sciences Inc....
...5(36); doi:10.1038/scibx.2012.968 Published online Sept. 13, 2012 Flow cytometry method covered by patents owned by DVS Sciences...
BioCentury | Aug 27, 2012
Tools & Techniques

Network profiling

...to find partners to develop and commercialize treatments for cancer and autoimmune indications using SCNP. DVS Sciences Inc....
...is on DVS's scientific advisory board. Companies and Institutions Mentioned Celgene Corp. (NASDAQ:CELG), Summit, N.J. DVS Sciences Inc....
Items per page:
1 - 10 of 15